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 Histological features and genetic profiles of gastric metaplastic tissue are well 
characterized in humans but not in dogs. The objective of this retrospective study 
was to better characterize the metaplastic tissue observed adjacent to canine 
gastric carcinoma. The histological specimens of 91 dogs diagnosed with gastric 
carcinoma were re-evaluated and Alcian Blue PAS staining at pH 2.5 was 
performed to find areas of intestinal metaplasia. Metaplasia was histologically 
classified according to Jass and Filipe classification. From samples with at least 
one focus of metaplasia, three sections were prepared for histochemical and 
immunohistochemical staining for p53 and c-erb 2 proteins.  35 of the 91 
specimens demonstrated areas of intestinal metaplasia (27% complete and 11% 
incomplete). Nuclear positive immunolabeling for p53 was detected in 21 out of 
35 cases of intestinal metaplasia. Immunohistochemical staining for c-erb 2 was 
detected in 31 out of 35 cases of intestinal metaplasia. There was a statistically 
significant correlation between c-erb2 and p53 expression in metaplastic tissue 
and in the adjacent neoplasia. 
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INTRODUCTION 
 
According to the current literature, carcinoma is the 
most common gastric neoplasm in dogs. Most animals 
with gastric neoplasia are relatively asymptomatic until 
the disease is advanced enough to disturb gastric function. 
Symptoms are frequently mild and a-specific in end-stage 
patients. Moreover, there is low client compliance in 
performing several consecutive endoscopies and gastric 
biopsies to monitor the possible multi-steps progression 
from gastritis to gastric neoplasia. Therefore, at the time 
of clinical presentation, tumours are often at an advanced 
stage resulting in a poor prognosis with limited treatment 
options (Minami, 2013). 
Curative resection is often complicated by diffuse 
infiltration and a frequently debilitated patient. 
According to actual literature, there are no validated pre-
neoplastic lesions of gastric carcinoma, even if recently 
a type of hypertrophic gastropathy like Ménétrier disease 
has been associated with possible predisposition to 
gastric cancer development (Lecoindre et al., 2012; 
Munday et al., 2012). 
 In humans areas of intestinal metaplasia (IM) in the 
gastric mucosa adjacent to gastric carcinoma are 
frequently described (Correa et al., 2010). IM is a well- 
known condition in human pathology as it occurs in 
response to a chronic mucosal insult and it is considered a 
precancerous lesion, part of the Correa’s cascade, a multi-
step progression from chronic gastritis to cancer (Correa, 
1992). In human medicine, gastric IM is histologically 
classified according to Jass and Filipe classification as 
complete IM (type 1) or incomplete IM (subdivided into 
type 2 and type 3), according to the various degree of 
epithelium differentiation toward a nearly complete small 
intestinal absorbent columnar cells. 
In veterinary medicine, the occurrence of IM in 
response to a chronic mucosal lesion has been reported 
(Wang et al., 2000; Gualtieri et al., 2006; Rychlik et al., 
2009; Gibson et al., 2010) although histological features 
and clinical behaviour have never been described.  A 
possible correlation between IM and gastric tumour 
development has never been investigated.  
In one of our patient we could observe the 
progression of IM to dysplasia and mucinous carcinoma 
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after 2 months. Because of this specific patient and a 
previous study conducted by the authors about IM and 
chronic gastritis (Cocci et al., 2008), we started reviewing 
cases of dog gastric carcinomas (GC) in order to localize 
areas of IM associated with neoplasia. The first aim of this 
study was to histologically classify the metaplastic 
changes present in the mucosa adjacent to canine GC. It 
has been largely demonstrated that the accumulation of 
multiple genetic alterations plays a pivotal role in tumour 
development in many organs (Waraya et al., 2015). 
In particular, the inactivation of the onco-suppressor 
p-53 gene appears to be involved in the carcinogenesis of 
various neoplasms (Waraya et al., 2015) and is frequently 
evident in dysplastic epithelium (Carrasco et al., 2011). C-
erb2 gene mutated forms promotes neoplastic 
transformation and its overexpression is involved in the 
carcinogenesis of mammary and pulmonary ductal 
carcinoma and of squamous cell carcinoma (Zheng et al., 
2010). Overexpression of c-erb2 has also been 
demonstrated in 2 dog gastric carcinomas (Terragni et al., 
2014). The second aim of this study was to investigate the 
possible neoplastic evolution of metaplastic tissue through 
the evaluation of p53 and c-erb 2 proteins expression in 
metaplastic epithelium. 
 
MATERIALS AND METHODS 
 
This retrospective study included 91 dogs presented 
to the University of Milan between January 2004 and 
2012, with histopathological evidence of GC on either 
endoscopic or surgical biopsies.  
The same two pathologists performed all the analysis. 
The paraffin-embedded samples were classified 
histologically according to the World Health Organization 
of Tumours of Domestic Animals guidelines.  According 
to the growth pattern 5 types of GC were found: tubular 
carcinoma, papillary carcinoma, mucinous carcinoma, 
signet-ring cell and undifferentiated carcinoma. 
Slides were reviewed with the aim to identify 
metaplastic changes adjacent to neoplastic lesions. 
Intestinal metaplasia was histologically classified 
according to Jass and Filipe (Jass et al., 1980). Metaplasia 
was considered Complete when gastric epithelium 
resembled the epithelium of the small intestine, with 
goblet cells secreting acid mucins and absorbent columnar 
cells with a well-developed brush border, and occasional 
Paneth cells at the base of the crypts. 
IM was classified as Incomplete (type 2) when both 
goblet cells and columnar cells secreting neutral mucins 
were observed, in absence of mature absorbent cells. 
Metaplasia was considered Incomplete (type 3) when cells 
appear more differentiated towards intestinal epithelium, 
although with some degree of disorganization in the 
glandular architecture, with presence of acid mucins 
secreting cells. From samples with at least one focus of 
IM, three white sections were prepared for histochemical 
and immunohistochemical staining.  
Alcian Blue PAS staining at pH 2.5 was performed to 
evaluate the content of acid (intestinal) or neutral (gastric) 
mucins.  The glass slides were deparafinized in xilene and 
rehydrated in Ethanol, rinsed in distilled water and stained 
in Alcian Blue Solution for 30 minutes. Slides were rinsed 
in distilled water and counterstained in nuclear Red 
Solution for 5 minutes. Washing in running tape water 
and dehydrating with Ethanol for 5 minutes was then 
done, followed by clearing with Xilene for 3 minutes, 
mounting and cover slipping. Strongly acidic sulphated 
mucosubstances were stained in blue, nuclei in pink to red 
and cytoplasms in pale pink. 
Additional sections were cut on poly-L-lysine coated 
glass slides and air dried overnight, deparafinized in 
xylene and dehydrated in descending dilutions of ethanol. 
For the antigen retrieval, slides were microwaved in 10 
mmol/L sodium citrate buffer (pH 6.0) at 10 min intervals 
for a total of 20 min. Endogenous peroxidase activity was 
blocked by 10 min of incubation with 3% hydrogen 
peroxidase at room temperature. The sections were then 
incubated with monoclonal mouse antibodies p53 (clone 
Y5 Epitomics) and c-erbB-2 (polyclonal oncoprotein Scy-
Tek) for 30 min.  Sections were washed with PBS, 
incubated with biotinylated secondary antibody at room 
temperature for 30 min. Diaminobenzidine was finally 
employed as chromogenic and sections were 
counterstained with Harris Hematoxylin. Sections of 
canine mammary carcinoma know to express tested 
antigens were used as positive control. Negative controls 
were obtained by substituting the primary antibody with 
an unrelated serum. Areas of gastric carcinoma included 
in the sections were used as an internal positive control. 
Sections of normal gastric mucosa were employed as a 
negative control. 
Immunohistochemical evaluation was performed 
counting positive cells in a total of 100 cells in 5 random 
fields at 40X magnification. Immunostaining was 
considered positive for p53 if the reaction took place in 
the nucleus and positive for c-erb 2 if it took place in the 
cytoplasm. Immunohistochemical index was calculated as 
the average of positive cells in 5 random fields at 40X.  
Statistical analyses were performed with Graph Pad 
Prism 6, using Fisher exact test to compare expression 
indexes with pathological parameters. Correlation among 
different variables was determined using Spearman rank 
correlation analysis. P≤0.05 was considered statistically 
significant. 
 
RESULTS  
 
Study population characteristics: The median age was 
8.73 years (range from 4 to 16 years) with 59 males and 
32 females. Specimens came from 22 different breeds.  
The most common was the Mixed Breed (41.7%) 
followed by the Boxer (7.7%), Dalmatian (5.5%), Belgian 
Shepherd (4.4%) and Newfoundland (4.4%). Dog with IM 
were 36 with an average age of 10 years. Breeds with IM 
were Mixed Breed (n=13), Newfoundland (n=3), Belgian 
Sheppard (n=3), Beagle (n=2), Border Collie (n=2), Dogo 
Argentino (n=2), Jack Russell Terrier (n=2), Scottish 
Sheppard (n=1), Siberian Husky (n=1), German Sheppard 
(n=1), English Setter (n=1), Lagotto (n=1), Labrador 
(n=1), Dalmatian (n=1), Chow-Chow (n=1), French Boule 
Dogue (n=1).  
 
Histological examination: Of the 91 cases evaluated, 40 
were tubular adenocarcinomas (44%), 5 mucinous 
carcinomas (5%), 44 signet ring carcinomas (48%) and 2 
were undifferentiated carcinomas (2%). The most frequent 
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locations were the small curvature and the pyloric antrum 
(33%). A focus of IM was observed in 35 specimens 
(38%). In agreement with the above-mentioned 
histological criteria, 25 cases of complete IM (27%) (Fig. 
1, Fig. 2) and 10 cases of incomplete IM type 2 (Fig. 3) 
(11%) were found. IM was associated with tubular and 
diffuse or signet-ring carcinoma (Table 1). 
 In the Complete IM, the gastric epithelium appeared 
“raised” in irregular pseudo villous structures covered by 
cylindrical gastric epithelial cells frequently together with 
Alcian Blue PAS positive goblet cells. Absorbent 
enterocytes with a brush border and non-absorbent 
columnar epithelium with abundant cytoplasm and basal 
nucleus were also observed. These cells showed acid 
mucins secretion with absence of hyperplasia or villiform 
structures. No type 3 IM was observed. In only one case a 
previous tissue sample was available for comparison. It 
showed a complete Intestinal Metaplasia without 
histological signs of GC. 
 
Immunohistochemistry: Nuclear positive immune-
labeling for p53 was detected in 21 out of 35 cases of IM 
(60%). Immunohistochemical staining for c-erb 2 was 
detected in the cytoplasm of cells in 31 out of 35 cases of 
IM (89%). The values of cell immune-expression for the 
p53 and c-erb 2 antibodies in the areas of IM and in the 
neoplastic portion are reported in Graph 1 and Graph 2. 
 
Statistics: There was a statistically significant correlation 
between c-erb2 expression in metaplastic tissue and in the 
adjacent neoplasia with a P=0.00598 and a R=0.455. 
There was also a statistically significant correlation 
between p53 expression in IM tissue and adjacent 
neoplasia with a P=0.00137 and a R=0.519. There was no 
correlation between c-erb2 and p53 expression in gastric 
carcinomas (P=0.52556, R=-0.1119). There was no 
correlation between c-erb2 and p53 in metaplastic area 
(P=0.18183, R=-0.2314). 
 
DISCUSSION 
 
To the authors’ knowledge the present study proves 
for the first time in veterinary medicine the spontaneous 
occurrence and the frequency of complete and incomplete 
IM in the context of gastric carcinoma in dogs. Previously 
gastric IM has been only experimentally inducted in 
stomach of Beagle dogs by combining treatment of oral 
administration of N-methyl-N'-nito-N-nitrosoguanidine 
and ranitidine with X-ray irradiation. This was done to 
create an animal model for scientific research purpose 
(Wang et al., 2000). 
Age and male to female ratio of dogs in our study 
matched with reported literature data about gastric 
carcinoma. In literature, a breed predisposition has 
been reported for the Rough Collie, Staffordshire 
terrier, Chow-Chow, Bouvier des Flandres and 
Groenendael and a familial occurrence has been 
described in Belgian Shepherds. On the contrary, the 
breed most represented in this study was the mixed breed 
(41.7%), but this may be explained by different 
population trends in different countries. The mixed breed 
was also the one most associated with gastric IM. 
 
 
 
Fig. 1: Complete gastric intestinal metaplasia with prominent goblet 
cells replacing the normal gastric epithelium. Sialomucines in goblet cells 
stained in Periodic acid–Schiff–Alcian blue. Bar 50 μm. 
 
 
 
Fig. 2: Complete IM. Gastric antral mucosae lined of columnar cells 
with brush-border and goblet cells mucinous secernent. Alcian PAS; 
10X Bar 50 μm.  
 
 
 
Fig. 3: Incomplete IM: presence of goblet cells between the cylindrical 
cells lining antral gastric mucosa. No obvious brush border. E.E. 10X. 
Bar 50 μm. 
 
Table 1: Correlation between tumour pattern and metaplasia pattern 
Tumour pattern IM pattern                            n° 
Adenocarcinoma Complete metaplasia            11 
Carcinoma signet ring Incomplete metaplasia           7 
Adenocarcinoma Incomplete metaplasia           2 
Carcinoma signet ring Complete metaplasia            13 
Mucinous Adenocarcinoma Incomplete metaplasia           1 
Mucinous Adenocarcinoma Complete metaplasia             1 
IM; Intestinal Metaplasia. 
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Fig. 4: Complete IM: gastric mucosae with pseudovillous structures, 
cylindrical epithelial gastric cells and globet acid mucins secreting cells. 
Mucinous adenocarcinoma infiltranting mucosae and submucosae. Alcian 
PAS 4X. Bar 50 μm.  
 
 
 
Fig. 5: Endoscopic picture of a 9-year old male Rough Collie. 
Endoscopic diagnosis of gastritis. Histology showed presence of 
Complete IM on the lesser curvature. 
 
 
 
Fig. 6: Endoscopic picture of the same dog two months later.  
Adenocarcinoma of the lesser curvature of the stomach. 
 
In humans IM derives from gastric stem cells 
differentiating into cells of the small intestine, in 
particular into absorbent, goblet and Paneth cells. This 
sequela generally occurs after a chronic inflammation 
induced by Helicobacter pylori infection (Correa et 
al., 2010). 
Gastric cancer is therefore generally believed to 
develop through a multistep progression from chronic 
gastritis to atrophic gastritis, intestinal metaplasia, 
dysplasia and at last cancer. This kind of gastric 
carcinogenesis is often called Correa’s cascade (Correa 
1992). A complete Correa’s cascade has not been yet 
identified in dogs and atrophic gastritis has been rarely 
reported in this species. Only in Lundehund dogs atrophic 
gastritis has been associated with possible development of 
gastric adenocarcinoma (Qvigstad et al., 2008). Unlike 
human medicine, in which IM is classified into three 
subtypes, in this study only two patterns were found: 
Complete type 1-like and the Incomplete type 2-like. 
The first is characterized by a pseudo villous aspect 
of the gastric mucosa with the presence of enterocytes 
secreting acid mucins, goblet cells and a scarce brush 
border. The Incomplete type 2 is characterized by 
irregular lengthening of the gastric foveolae with 
occasional goblet cells secreting acid mucins, absence of 
enterocytes and brush border.  
The complete IM shared histological features with the 
human counterpart and, as observed in humans, IM was 
frequently associated with tubular and diffuse or signet-
ring carcinoma. In human medicine, the subtype of IM has 
a prognostic value. Complete IM is associated with a low 
risk of gastric carcinoma development, while Type 3 (so-
called colic) is strongly associated with carcinoma 
development.  A 10-year follow-up study showed that 
human patients with type 3 IM were four times more 
likely to develop gastric carcinoma than patients with type 
1 IM (Filipe et al., 1994). 
In some IM positive-dogs we observed gastric lesions 
characterized by non-absorbent columnar epithelium 
secreting acid mucins in the absence of hyperplasia or 
villiform structures. 
The authors have frequently observed this kind of 
lesion as an antral reactive phenomenon following biliary 
reflux (Fig. 4). This agrees with a study from Rychlik, 
Nieradka et al. (2009) in which incomplete IM was found 
in gastric mucosa biopsies of dogs with inflammatory 
bowel disease and biliary reflux. 
Previous veterinary medicine reports (Gualtieri et al., 
2006; Gibson et al., 2010) show that in animals IM is not 
associated to pathognomonic endoscopic features. 
This happens also in human medicine. as 
conventional endoscopic identification of intestinal 
metaplasia has a high rate of inter-observer variability and 
correlates poorly with the histological findings. Intestinal 
metaplasia usually appears as flat mucosa and shows few 
morphologic changes. In some rare human patients, IM 
may be associated with a patchy or villous aspect of 
gastric mucosa, with whitish plaques or with a 
homogeneous discoloration (Lin et al., 1999). Nowadays 
in human and veterinary medicine, endoscopic targeted 
biopsies of IM can be done after methylene blue gastric 
staining, a stain able to tinge the normal absorptive 
epithelium of the small intestine (Calle et al., 2013). 
Histological staining of endoscopic or surgical 
biopsies is currently a reliable exam to identify IM. 
Unfortunately, in this study it was not possible to evaluate 
the follow-up biopsies of the subjects examined because 
most of the specimens came from animals euthanized 
following the diagnosis of GC. In veterinary medicine the 
low clients’ compliance prevents veterinary surgeons to 
perform several endoscopies and biopsies to monitor the 
possible multi-steps progression from gastritis to AG, IM 
and gastric neoplasia. 
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Graph 1:  Correlation of immunoexpression of c-erb2 protein in 
intestinal metaplastic lesion and in gastric carcinoma. 
 
 
 
Graph 2: Correlation of immunoexpression of p-53 protein in 
intestinal metaplastic lesion and gastric carcinoma. 
 
Only in one of our patient, a 9-year old male Rough 
Collie, we were able to detect the multi-step progression 
of the pathology through serial gastrointestinal 
endoscopies and biopsies. This dog was at first diagnosed 
with gastritis associated to complete IM (Fig. 5) and then 
developed intra-mucosal carcinoma associated to 
complete IM (Fig. 6). This single case and the results of 
this work suggest a possible correlation between IM and 
gastric carcinoma development through a multi-step 
process resembling the Correa’s cascade. 
However, it is now impossible for us to affirm that a 
clear association between IM and GC exists. Further 
studies are needed to detect a complete Correa’s cascade 
in the canine species and we think that clinicians should 
consider routine endoscopic monitoring for animal 
diagnosed with gastric IM. Previous studies carried out on 
canine gastric carcinoma have pointed out an 
overexpression of the p53 protein in all types of 
carcinoma (Hattori, 2004). Carrasco et al. (2011) reported 
an association between degree of tumour infiltration and 
p53 expression, confirming the usefulness of p53 
expression as a prognostic factor.  
In our study, the immunohistochemical staining for 
p53 protein showed a positivity labelling of metaplastic 
intestinal cells adjacent to gastric carcinoma in 60% of our 
cases (Adj R2=0.33). A positive correlation was found 
between p53 expression in metaplastic tissue and in the 
adjacent neoplasia (P=0.00137, R=0.519). Positive 
immunolabeling was detected only in biopsies with 
Complete IM, where only goblet cells were present. 
Moreover, it was noteworthy that IM cells positive for 
p53 were often contiguous to carcinomatous areas leading 
to the hypothesis of malignant progression from IM to 
gastric carcinoma.  
A positive immunolabeling was also found for c-erb2 
protein in the 97.2% of metaplastic lesions (Adj 
R2=0.19). A positive correlation between c-erb2 
expression in metaplastic tissue and in the adjacent 
neoplasia was found (P=0.00598, R=0.455). Kanaya et al. 
(2002) associate the overexpression of c-erb 2 with the 
degree of malignancy and tumour infiltration in numerous 
canine epithelial neoplasia  
Moreover, in human medicine, the expression of c-
erb 2 has been recognized as responsible for the initial 
stage of mammary tumours. The overexpression of c-erb2 
proteins in the cells of the basal layer of ameloblastomas 
promotes the malignant transformation of keratinocytes 
(Groves et al., 1992). The identification of c-erb2 in 
metaplastic stomach cells of our specimens suggested its 
involvement in precancerous lesions as already reported 
by Rungsipapat et al. (2000).  
However, we detected no correlation between c-erb2 
and p53 expression in gastric carcinomas (P =0.52556, 
R=-0.1119). We detected no correlation between c-erb2 
and p53 in metaplastic areas (P=0.181836, R=-0.2314). 
Further studies are needed, possibly with a control group, 
to better evaluate the relationship between these two 
proteins expression. 
 
Conclusions: From the study it was concluded that 
Complete and Incomplete IM and overexpression of p53 
and c-erb 2 have a close relationship with gastric 
carcinoma. Further studies on a larger number of cases 
and clinical follow-up are necessary to define with greater 
scientific accuracy the role of intestinal metaplasia in 
canine gastric carcinoma development. 
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